Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ropivacaine (naropin) (1 trial)
sodium chloride (1 trial)
carboplatin (paraplatin) (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
indapamide (lozol) (1 trial)
losartan (cozaar) (1 trial)
pemetrexed (alimta) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Hypertension (Phase 3)
Neck Pain (Phase 4)
Trials (3 total)
Trial APIs (7 total)